Table of contents

ORIGINAL ARTICLE

• Genetic variation in ABCB1 influences paclitaxel pharmacokinetics in Japanese patients with ovarian cancer

  (1 April, 2006)

  H. Yamaguchi, T. Hishinuma, N. Endo, H. Tsukamoto, Y. Kishikawa, M. Sato, Y. Murai, M. Hiratsuka, K. Ito, C. Okamura, N. Yaegashi, N. Suzuki, Y. Tomioka, J. Goto
• Prognostic significance of tumor necrosis in ovarian cancer patients treated with neoadjuvant chemotherapy and interval surgical debulking (1 April, 2006)

  T. Le, P. Shahriari, L. Hopkins, W. Faught, M. Fung Kee Fung
• Extraperitoneal laparoscopic para-aortic lymphadenectomy for lymph node recurrence of fallopian tube carcinoma (1 April, 2006)

  O. CÓRDOBA, A. Gil-Moreno, J. De La Torre, J. M. Martínez-Palones, B. DÍAZ, J. Xercavins
• Brain metastases as isolated site of relapse in patients with epithelial ovarian cancer previously treated with platinum and paclitaxel-based chemotherapy (1 April, 2006)

  E. Kastritis, E. Efstathiou, D. Gika, G. Bozas, V. Koutsoukou, C. Papadimitriou, G. Pissakas, M. A. Dimopoulos, A. Bamias
• Relationship between p53-associated proteins and estrogen receptor status in ovarian serous neoplasms (1 April, 2006)

  E. Y. Cho, Y. L. Choi, S. W. Chae, J. H. Sohn, G. H. Ahn
• The evaluation of human papillomavirus DNA testing in primary screening for cervical lesions in a large Japanese population (1 April, 2006)

  M. Inoue, J. Sakaguchi, T. Sasagawa, M. Tango
• Implications regarding atypical squamous cells of undetermined significance among women residing in a US–Mexico border city (1 April, 2006)

  H. Greenberg, M. Duarte-Gardea, O. R. Quezada
• Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Melbourne, Australia (1 April, 2006)

  M. P. Stevens, S. N. Tabrizi, M. A. Quinn, S. M. Garland
• Prevalence of human papillomavirus types 16 and 18 in cervical adenocarcinoma and its precursors in Scottish patients (1 April, 2006)

  M. Tawfik El-Mansi, K. S. Cuschieri, R. G. Morris, A. R.W. Williams
• Serologic response to human papillomavirus 16 among Australian women with high-grade cervical intraepithelial neoplasia (1 April, 2006)

  S. N. Tabrizi, I. H. Frazer, S. M. Garland
• Reduction in prevalence of invasive cervical cancer in KwaZulu-Natal, South Africa: impact of the human immunodeficiency virus epidemic (1 April, 2006)

  M. Moodley
• Human papillomavirus–specific viral types are common in Mexican women affected by cervical lesions (1 April, 2006)

  P. Piña-Sánchez, D. M. Hernández-Hernández, R. LÓPEZ-ROMERO, G. VÁZQUEZ-ORTÍZ, C. PÉREZ-PLASENCIA, M. Lizano-Soberón, J. L. González-Sánchez, F. Cruz-Talonia, M. Salcedo
• Human papillomavirus prevalence in postradiotherapy uterine cervical carcinoma patients: correlation with recurrence of the disease (1 April, 2006)

  R. K. Singh, S. Maulik, S. Mitra, R. K. Mondal, P. S. Basu, S. Roychowdhury, C. K. Panda
• Prediction of high-grade cervical disease with human papillomavirus detection in women with glandular and squamous cytologic abnormalities (1 April, 2006)

  E. R.Z.M. De Oliveira, S. F.M. Derchain, L. O.Z. Sarian, S. H. Rabelo-Santos, R. C. Gontijo, A. Yoshida, L. A.L.A. Andrade, L. C. Zeferino
• An appraisal of the level of awareness and utilization of the Pap smear as a cervical cancer screening test among female health workers in a tertiary health institution (1 April, 2006)

  E. P. Gharoro, E. N. Ikeanyi
• Normal appearing endometrial cells in cervical smears of asymptomatic postmenopausal women have predictive value for significant endometrial pathology (1 April, 2006)

  A. G. Siebers, A. L.M. Verbeek, L. F. Massuger, J. M.M. Grefte, J. Bulten
• Prime-boost vaccination strategy in women with high-grade, noncervical anogenital intraepithelial neoplasia: clinical results from a multicenter phase II trial (1 April, 2006)

  A. N. Fiander, A. J. Tristram, E. J. Davidson, A. E. Tomlinson, S. Man, P. J. Baldwin, J. C. Sterling, H. C. Kitchener
• Outcomes of loop electrosurgical excision procedure for cervical neoplasia in human immunodeficiency virus–infected women (1 April, 2006)

  C. Kietpeerakool, J. Srisomboon, P. Suprasert, C. Phongnarisorn, K. Charoenkwan, C. Cheewakriangkrai, S. Siriaree, C. Tantipalakorn, A. Pantusart
• Psychologic morbidities prior to loop electrosurgical excision procedure in the treatment of cervical intraepithelial neoplasia (1 April, 2006)

  T. Le, L. Hopkins, C. Menard, W. Hicks-Boucher, J. Lefebvre, M. Fung Kee Fung
• The role of pretreatment squamous cell carcinoma antigen level in locally advanced squamous cell carcinoma of the uterine cervix treated by radiotherapy (1 April, 2006)

  I. Ogino, H. Nakayama, N. Okamoto, T. Kitamura, T. Inoue
• High–dose rate brachytherapy in the treatment of carcinoma of uterine cervix: twenty-year experience with cobalt after-loading system (1 April, 2006)

  A. Mosalaei, M. Mohammadianpanah, S. Omidvari, N. Ahmadloo
• Time course and outcome of central recurrence after radiation therapy for carcinoma of the cervix (1 April, 2006)

  P. J. Eifel, A. Jhingran, J. Brown, C. Levenback, H. Thames
• Postoperative radiation therapy improves prognosis in patients with adverse risk factors in localized, early-stage cervical cancer: a retrospective comparative study (1 April, 2006)

  Q. D. Pieterse, J. B.M.Z. Trimbos, A. Dijkman, C. L. Creutzberg, K. N. Gaarenstroom, A. A.W. Peters, G. G. Kenter
• An observational longitudinal study to evaluate miction, defecation, and sexual function after radical hysterectomy with pelvic lymphadenectomy for early-stage cervical cancer (1 April, 2006)

  Q. D. Pieterse, C. P. Maas, M. M. Ter Kuile, M. Lowik, M. A. Van Eijkeren, J. B.M.Z. Trimbos, G. G. Kenter
• Lymphedema and bladder-emptying difficulties after radical hysterectomy for early cervical cancer and among population controls (1 April, 2006)

  K. Bergmark, E. ÅVALL-LUNDQVIST, P. W. Dickman, L. Henningsohn, G. Steineck
• Vaginal dilation associated with pelvic radiotherapy: a UK survey of current practice (1 April, 2006)

  I. D. White, S. Faithfull
• Surgery alone or surgery with a combination radiation or chemoradiation for management of patients with bulky-stage IB2 cervical carcinoma (1 April, 2006)

  J. P. Micha, B. H. Goldstein, M. A. Rettenmaier, J. V. Brown, C. R. John, M. Markman
• Chemotherapy with mitomycin c, ifosfamide, and cisplatin for recurrent or persistent cervical cancer (1 April, 2006)

  K. Serkies, J. Jassem, R. Dziadziuszko
• Salvage chemotherapy with a combination of paclitaxel, ifosfamide, and cisplatin for the patients with recurrent carcinoma of the uterine cervix (1 April, 2006)

  C. H. Choi, T.-J. Kim, S.-J. Lee, J.-W. Lee, B.-G. Kim, J.-H. Lee, D.-S. Bae
• Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer (1 April, 2006)

  F. C. Maluf, A. L. Leiser, C. Aghajanian, P. Sabbatini, S. Pezzulli, D. S. Chi, J. K. Wolf, C. Levenback, E. Loh, D. R. Spriggs
• Pemetrexed (Alimta®, LY231514) demonstrates clinical activity in chemonaive patients with cervical cancer in a phase II single-agent trial (1 April, 2006)

  L. Goedhals, A. L. Van Wiyk, B. L. Smith, S. J. Fourie
• Accuracy of magnetic resonance imaging of inguinofemoral lymph nodes in vulval cancer (1 April, 2006)

  K. Singh, C. O. Orakwue, H. Honest, M. Balogun, C. Lopez, D. M. Luesley
• Lymph node metastasis and lymph vascular space invasion in microinvasive squamous cell carcinoma of the uterine cervix (1 April, 2006)

  K. B.M. Lee, J. M. Lee, C. Y. Park, K. B. Lee, H. Y. Cho, S. Y. Ha
• Assessment of pelvic lymph node micrometastatic disease in stages IB and IIA of carcinoma of the uterine cervix (1 April, 2006)

  Jhtg Fregnani, M. R.D.O Latorre, P. R. Novik, A. Lopes, F. A. Soares
• Benign vascular tumors of female genital tract (1 April, 2006)

  R. Gupta, S. Singh, S. Nigam, N. Khurana
• Clinical and histopathologic factors related to prognosis in primary squamous cell carcinoma of the vagina (1 April, 2006)

  K. Hellman, M. Lundell, C. Silfverswärd, B. Nilsson, A. C. Hellström, B. Frankendal
• Paget's disease of the vulva: clinicopathologic study of type 1 cases treated at a single institution (1 April, 2006)

  H. Niikura, H. Yoshida, K. Ito, T. Takano, H. Watanabe, S. Aiba, N. Yaegashi
• Plasma proteomic profiling for detecting and differentiating in situ and invasive carcinomas of the uterine cervix

  (1 April, 2006)

  Y. W. Lin, H. C. Lai, C. Y. Lin, J. Y. Chiou, H. A. Shui, C. C. Chang, M. H. Yu, T. Y. Chu
• Validation of tissue microarray technology using cervical adenocarcinoma and its precursors as a model system (1 April, 2006)

  M. Tawfik El-Mansi, A. R.W. Williams
• Promoter methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical cancer: correlation with clinicopathologic characteristics (1 April, 2006)

  D. H. Jeong, M. Y. Youm, Y. N. Kim, K. B. Lee, M. S. Sung, H. K. Yoon, K. T. Kim
• Suppression of human cervical cancer cell lines Hela and DoTc2 4510 by a mixture of lysine, proline, ascorbic acid, and green tea extract (1 April, 2006)

  M. W. Roomi, V. Ivanov, T. Kalinovsky, A. Niedzwiecki, M. Rath
• X chromosomal and autosomal loss of heterozygosity and microsatellite instability in human cervical carcinoma (1 April, 2006)

  J. Edelmann, K. Richter, C. HÄNEL, S. Hering, L. C. Horn
• Evaluation of PTEN expression in cervical adenocarcinoma by tissue microarray

  (1 April, 2006)

  Mtawfik El-Mansi, A. R.W. Williams
• Effects of 17β-estradiol and progesterone on transcription of human papillomavirus 16 E6/E7 oncogenes in CaSki and SiHa cell lines (1 April, 2006)

  M. Ruutu, N. Wahlroos, K. Syrjänen, B. Johansson, S. Syrjänen
• Association between HLA-DQB1 and cervical dysplasia in Vietnamese women (1 April, 2006)

  C. Lema, A. L. Fuessel-Haws, L. R. Lewis, P. L. Rady, P. Lee, E. A. Turbat-Herrera, Q. He, L. T. Nguyen, S. K. Tyring, D. D. Dao
• Interleukin-6 polymorphisms and the risk of cervical cancer (1 April, 2006)

  N. C. Nogueira De Souza, S. M.F. Brenna, F. Campos, K. J. Syrjänen, E. C. Baracat, I. D.C.G. Silva
• Telomerase activity in the vaginal margins of radical hysterectomy in patients with carcinoma of the cervix: correlation with histology and human papillomavirus (1 April, 2006)

  S. A. Triginelli, A. L. Silva-Filho, P. Traiman, F. M.U. Silva, M. C.G. Chaves-Dias, G. C. Oliveira, J. R. Cunha-Melo
• A subgroup of HOX Abd-B gene is differentially expressed in cervical cancer (1 April, 2006)

  R. LÓPEZ, E. Garrido, G. VÁZQUEZ, P. Piña, C. PÉREZ, I. Alvarado, M. Salcedo
• Matrix metalloproteinases-2 and -9 in cervical cancer: different roles in tumor progression (1 April, 2006)

  M. Rauvala, K. Aglund, U. Puistola, T. Turpeenniemi-Hujanen, G. Horvath, R. Willén, U. Stendahl
• COX-1 and COX-2 expression in stage I and II invasive cervical carcinoma: relationship to disease relapse and long-term survival (1 April, 2006)

  R. Athavale, K. Clooney, J. O'HAGAN, H. Shawki, A. H. Clark, J. A. Green
• Expression of thymidine phosphorylase as an effect prediction factor for uterine cervical squamous cell carcinoma after radiotherapy: an immunohistochemical study (1 April, 2006)

  M. Nakashima, T. Nakano, Y. Ametani, H. Funamoto, A. Uchiyama, A. Miwa, S. Miyata, M. Shoji, T. Kondo, S. Satake, Y. Kojima
• Hypoxia and expression of the proapoptotic regulator BNIP3 in cervical cancer (1 April, 2006)

  C. Leo, L. C. Horn, M. HÖCKEL
• Analysis of the in vitro synergistic effect of 5-fluorouracil and cisplatin on cervical carcinoma cells

  (1 April, 2006)

  E. K. Yim, S. B. Lee, K. H. Lee, C. J. Kim, J. S. Park
• Statistical analysis of pathologic risk factors for intramyometrial lymphvascular space involvement in myoinvasive endometrial carcinoma (1 April, 2006)

  L. H. Honorè, J. Hanson
• Endometrial cancer patients have a significant risk of harboring isolated tumor cells in histologically negative lymph nodes (1 April, 2006)

  C. A. Amezcua, H. R. Macdonald, C. A. Lum, W. Yi, L. I. Muderspach, L. D. Roman, J. C. Felix
• Predictability of retroperitoneal lymph node metastasis by using clinicopathologic variables in surgically staged endometrial cancer (1 April, 2006)

  C. Taskiran, K. Yuce, P. O. Geyik, T. Kucukali, A. Ayhan
• Cholecystectomy and endometrial cancer: a marker of long-term elevated estrogen exposure? (1 April, 2006)

  L. M. Morimoto, P. A. Newcomb, J. M. Hampton, A. Trentham-Dietz
• Loss of p16 in recurrent malignant mixed müllerian tumors of the uterus (1 April, 2006)

  B. Robinson-Bennett, R. Z. Belch, A. C. Han
• Clinical outcomes of uterine sarcomas: results from 14 years worth of experience in the Kinki district in Japan (1990–2003) (1 April, 2006)

  K. Kokawa, K. Nishiyama, M. Ikeuchi, Y. Ihara, N. Akamatsu, T. Enomoto, O. Ishiko, S. Motoyama, S. Fujii, N. Umesaki
• Combined adjuvant cisplatin and ifosfamide chemotherapy and radiotherapy for malignant mixed müllerian tumors of the uterus (1 April, 2006)

  L. Wong, H. T. See, H. S. Khoo-Tan, J. S. Low, W. T. Ng, J. J. Low
• Use of trastuzumab in the treatment of metastatic endometrial cancer (1 April, 2006)

  E. Jewell, A. A. Secord, T. Brotherton, A. Berchuck
• Serum proteomic features for detection of endometrial cancer (1 April, 2006)

  L. R. Zhu, W. Y. Zhang, L. Yu, Y. H. Zheng, J. Z. Zhang, Q. P. Liao
• Combined E-cadherin, α-catenin, and β-catenin expression is a favorable prognostic factor in endometrial carcinoma (1 April, 2006)

  A. N. Scholten, R. Aliredjo, C. L. Creutzberg, Vthbm Smit
• Microsatellite instability in endometrioid endometrial carcinoma: correlation with clinically relevant pathologic variables (1 April, 2006)

  L. H. Honorè, J. Hanson, S. E. Andrew
• The detection of microsatellite instability in blind endometrial samples—a potential novel screening tool for endometrial cancer in women from hereditary nonpolyposis colorectal cancer families? (1 April, 2006)

  M. J. Hewitt, N. Wood, N. D. Quinton, R. Charlton, G. Taylor, E. Sheridan, S. R. Duffy
• Heparanase expression in both normal endometrium and endometrial cancer (1 April, 2006)

  J. Kodama, T. Kusumoto, N. Seki, T. Matsuo, Y. Ojima, K. Nakamura, A. Hongo, Y. Hiramatsu
• CYP1A1 gene polymorphism and risk of endometrial hyperplasia and endometrial carcinoma (1 April, 2006)

  I. Esinler, D. Aktas, M. Alikasifoglu, E. Tuncbilek, A. Ayhan
• Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium (1 April, 2006)

  S. Erkanli, F. Kayaselcuk, E. Kuscu, T. Bagis, F. Bolat, A. Haberal, B. Demirhan
• MSH2 splice site mutation and endometrial cancer

  (1 April, 2006)

  F. Bianchi, S. Rosati, L. Belvederesi, C. Loretelli, R. Catalani, A. Mandolesi, R. Bracci, I. Bearzi, E. Porfiri, R. Cellerino
• Targeting topoisomerase IIa in endometrial adenocarcinoma (1 April, 2006)

  E. Tsiambas, D. Alexopoulou, S. Lambropoulou, K. Gerontopoulos, P. Karakitsos, A. Karameris
• Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia (1 April, 2006)

  T. Turan, O. Karacay, G. Tulunay, N. Boran, S. Koc, S. Bozok, M. F. Kose